Related Experiment Video
Updated: Feb 16, 2026

A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma
Published on: September 30, 2021
Liver X receptors as potential targets for cancer therapeutics
Xiaoli Ju1, Pan Huang1, Miao Chen1,2
1Department of Pathology, School of Medicine, Jiangsu University, Zhenjiang, Jiangsu 212013, P.R. China.
Abstract:
Liver X receptors (LXRs) are important members of the nuclear receptor family that were originally determined to function in cholesterol transport and the regulation of immune responses. Synthetic LXR ligands have been developed to treat various diseases including diabetes, Alzheimer's disease and atherosclerosis. Previous studies have suggested that LXRs are also involved in numerous types of cancer and are therefore potential targets for cancer therapeutics. The present review summarizes LXR ligands and their mechanisms of action, the effects of LXRs in different types of cancer and their potential applications in clinical treatment. Together, the studies discussed in the present review indicate that LXRs may be potential targets for cancer therapeutics.
Insights
Liver X receptors (LXRs) regulate cholesterol and immunity. Emerging research suggests LXRs are promising therapeutic targets for various cancers, offering new avenues for clinical treatment.
Area of Science:
- Molecular biology
- Endocrinology
- Oncology
Background:
- Liver X receptors (LXRs) are nuclear receptors involved in cholesterol transport and immune responses.
- Synthetic LXR ligands are utilized for treating metabolic and cardiovascular diseases.
- Emerging evidence implicates LXRs in the pathogenesis of various cancers.
Purpose of the Study:
- To review current knowledge on LXR ligands and their mechanisms.
- To summarize the role of LXRs in different cancer types.
- To evaluate the potential of LXRs as cancer therapeutic targets.
Main Methods:
- Literature review of studies on LXR ligands and their effects in cancer.
- Analysis of the mechanisms of action of LXRs in cancer.
- Synthesis of data on clinical applications of LXR-targeting therapies.
Main Results:
- LXR ligands exhibit diverse mechanisms of action.
- LXRs play significant roles in the development and progression of multiple cancer types.
- Preclinical data suggest potential for LXR-based cancer treatments.
Conclusions:
- LXRs are implicated in cancer and represent potential therapeutic targets.
- Further research into LXR modulation could lead to novel cancer therapies.
- Clinical translation of LXR-targeting strategies warrants investigation.
Related Concept Videos
Targeted Cancer Therapies
There are several types of targeted therapies against...
Transducer Mechanism: Nuclear Receptors
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
Liver Regeneration
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are...
Transducer Mechanism: Enzyme-Linked Receptors
Major types that are helpful drug targets include:
lncRNA - Long Non-coding RNAs

